Explore the complete record of transactions filed by 李寅, Director. Officer active across 1 companies, notably 九洲集团. Cumulatively, 33 disclosures have been logged. Regulator: AMF. All data is free.
Declarations 33 total
Executives ● Sale百 百普赛斯 7 SZSE 5,900 shares
SZSE:173000009867117900 · 4 Dec 2025
Executives ● Sale百 百普赛斯 7 SZSE 6,300 shares
SZSE:173000009860701820 · 3 Dec 2025
Executives ● Sale百 百普赛斯 11 SZSE 9,300 shares
SZSE:173000009628394560 · 13 Oct 2025
Executives ● Sale百 百普赛斯 11 SZSE 11,800 shares
SZSE:173000009625471900 · 10 Oct 2025
Executives ● Sale九 九洲集团 7 SZSE 20,000 shares
SZSE:173000009171309200 · 7 Jul 2025
Executives ● Sale仙 仙乐健康 7 SZSE 2,100,000 shares
SZSE:173000008295273920 · 25 Nov 2024
Executives ● Purchase仙 仙乐健康 7 SZSE 15,900 shares
SZSE:173000007961467800 · 15 Aug 2024
Ideal exit: 12 May 2025 (T+270) Executives ● Purchase仙 仙乐健康 7 SZSE 6,800 shares
SZSE:173000007956696160 · 14 Aug 2024
Ideal exit: 11 May 2025 (T+270) Executives ● Purchase英 英科医疗 7 SZSE 121,000 shares
SZSE:173000007417101060 · 22 Mar 2024
Ideal exit: 17 Dec 2024 (T+270) Executives ● Purchase九 九洲集团 21 SZSE 181,000 shares
SZSE:173000009655466000 · 27 May 2022
Ideal exit: 21 Feb 2023 (T+270) Executives ● Purchase九 九洲集团 21 SZSE 559,200 shares
SZSE:173000009655464600 · 24 May 2022
Ideal exit: 18 Feb 2023 (T+270) Executives ● Purchase九 九洲集团 18 SZSE 49,600 shares
SZSE:173000009655462850 · 17 May 2022
Ideal exit: 11 Feb 2023 (T+270) Executives ● Purchase九 九洲集团 18 SZSE 327,000 shares
SZSE:173000009655461470 · 16 May 2022
Ideal exit: 10 Feb 2023 (T+270) Executives ● Purchase九 九洲集团 7 SZSE 362,800 shares
SZSE:173000009655458800 · 13 May 2022
Ideal exit: 7 Feb 2023 (T+270) Executives ● Purchase九 九洲集团 7 SZSE 31,300 shares
SZSE:173000009655453340 · 12 May 2022
Ideal exit: 6 Feb 2023 (T+270) Executives ● Sale昂 昂立教育 11 SSE 2,000 shares
SSE:173000005220655700 · 13 Jan 2022
Executives ● Sale英 英科医疗 22 SZSE 2,242,050 shares
SZSE:173000005069817150 · 12 Nov 2021
100 shares
SSE:173000004974899000 · 13 Oct 2021
Executives ● Purchase昂 昂立教育 7 SSE 9,400 shares
SSE:173000004974898980 · 11 Oct 2021
Ideal exit: 8 Jul 2022 (T+270) 100 shares
SSE:173000004967629660 · 8 Oct 2021
Executives ● Sale英 英科医疗 7 SZSE 63,000 shares
SZSE:173000004609545250 · 30 Jul 2021
Executives ● Sale英 英科医疗 22 SZSE 10,000 shares
SZSE:173000005688670140 · 30 Jul 2021
Executives ● Sale英 英科医疗 22 SZSE 547,163 shares
SZSE:173000004609545200 · 29 Jul 2021
Executives ● Sale英 英科医疗 22 SZSE 40,400 shares
SZSE:173000004604146300 · 28 Jul 2021
Executives ● Sale仙 仙乐健康 7 SZSE 7,200 shares
SZSE:173000004629073660 · 20 Jul 2021
25 of 33 declarations
Load more (8 remaining) About 李寅 Li Yin is a Director at Jiuzhou Group. He participates in strategic decision-making and overseeing the company's activities. His experience and expertise are valuable assets in guiding the company in a competitive environment.